Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-018931
Filing Date
2006-03-23
Accepted
2006-03-23 17:27:49
Documents
14
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-7537_110k.htm 10-K 1859753
2 MATERIAL CONTRACTS a06-7537_1ex10d29.htm EX-10.29 34228
3 MATERIAL CONTRACTS a06-7537_1ex10d30.htm EX-10.30 33089
4 CONSENTS OF EXPERTS AND COUNSEL a06-7537_1ex23d1.htm EX-23.1 3166
5 302 CERTIFICATION a06-7537_1ex31d1.htm EX-31.1 10762
6 302 CERTIFICATION a06-7537_1ex31d2.htm EX-31.2 10751
7 906 CERTIFICATION a06-7537_1ex32.htm EX-32 11211
8 GRAPHIC g75371ba01i001.jpg GRAPHIC 28085
9 GRAPHIC g75371ba01i002.jpg GRAPHIC 17683
10 GRAPHIC g75371ba01i003.jpg GRAPHIC 12414
11 GRAPHIC g75371ba01i004.jpg GRAPHIC 17004
12 GRAPHIC g75371ba01i005.gif GRAPHIC 30676
13 GRAPHIC g75371ba01i006.jpg GRAPHIC 22479
14 GRAPHIC g75371ba01i007.jpg GRAPHIC 12623
  Complete submission text file 0001104659-06-018931.txt   2159459
Mailing Address
Business Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
METABASIS THERAPEUTICS INC (Filer) CIK: 0001053221 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50785 | Film No.: 06706976
SIC: 2834 Pharmaceutical Preparations